Status:
COMPLETED
Indian Phenotype Registry
Lead Sponsor:
AstraZeneca
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-99 years
Brief Summary
This study is a non-interventional, multicentre observational study to be conducted at 1000 sites in India. The study targets to enrol approx. 50000 patients with approx. 50 patients per site. The stu...
Detailed Description
This study is a non-interventional, multicentre observational study to be conducted at 1000 sites in India. The study targets to enrol approx. 50000 patients with approx. 50 patients per site. The stu...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Male or female patients with 18 years and above.
- Patients who provide written informed consent.
- Patients with previously diagnosed with Diabetes Mellitus
- HbA1C report available within past 3 months
- Exclusion Criteria- None
Exclusion
Key Trial Info
Start Date :
December 11 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 14 2019
Estimated Enrollment :
40000 Patients enrolled
Trial Details
Trial ID
NCT03363594
Start Date
December 11 2017
End Date
June 14 2019
Last Update
June 16 2020
Active Locations (197)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Guntur, Andhra Pradesh, India, D1843R00282
2
Research Site
Kākināda, Andhra Pradesh, India, D1843R00282
3
Research Site
Madanapalle, Andhra Pradesh, India, D1843R00282
4
Research Site
Nellore, Andhra Pradesh, India, D1843R00282